Gingipains as candidate antigens for Porphyromonas gingivalis vaccine

Keio Journal of Medicine

Volumn 52, Issue 3, 2003, Pages 158-162

  Nakagawa, Taneaki ^a   Saito, Atsushi ^b   Hosaka, Yasuo ^a   Ishihara, Kazuyuki ^b  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Gingipain; Periodontal disease; Porphyromonas gingivalis; Vaccine

Indexed keywords

ANTIGEN; ARGININE; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; DNA VACCINE; GINGIPAIN R; LYSINE; PROTEINASE; VIRULENCE FACTOR;

ANTIBODY TITER; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; FIMBRIA; GRAM NEGATIVE ANAEROBIC BACTERIA; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUTH FLORA; NONHUMAN; PATHOGENICITY; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN DOMAIN; PROTEIN INDUCTION; REVIEW; SEQUENCE HOMOLOGY;

EID: 0141756255     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.52.158     Document Type: Review

References (41)

1. Nakagawa T, Yamada S, Tsunoda M, Sato T, Naito Y, Takazoe I, Okuda K: Clinical, microbiological, and immunological studies following initial preparation in adult periodontitis. Bull Tokyo Dent Coll 1990; 31: 321-331
2. Nakagawa T, Yamada S, Oosuka Y, Saito A, Hosaka Y, Ishikawa T, Okuda K: Clinical and microbiological study of local minocycline delivery (Periocline) following scaling and root planing in recurrent periodontal pockets. Bull Tokyo Dent Coll 1991; 32: 63-70
3. Mayrand D, Holt SC: Biology of asaccharolytic black-pigmented Bacteroides species. Microbiol Rev 1988; 52: 134-152
4. Sundqvist G: Pathogenicity and virulence of black-pigmented gram-negative anaerobes. FEMS Immunol Med Microbiol 1993; 6: 125-137
5. Cutler CW, Kalmar JR, Genco CA: Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol 1995; 3: 45-51
6. Lamont RJ, Jenkinson HF: Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998; 62: 1244-1263
7. Amano A, Kataoka K, Raj PA, Genco RJ, Shizukuishi S: Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin. Infect Immun 1996; 64: 4249-4254
8. Hanazawa S, Hirose K, Ohmori Y, Amano S, Kitano S: Bacteroides gingivalis fimbriae stimulate production of thymocyte-activating factor by human gingival fibroblasts. Infect Immun 1988; 56: 272-274
9. Ogawa T, Uchida H, Hamada S: Porphyromonas gingivalis fimbriae and their synthetic peptides induce proinflammatory cytokines in human peripheral blood monocyte cultures. FEMS Microbiol Lett 1994; 116: 237-242
10. Assuma R, Oates T, Cochran D, Amar S, Graves DT: IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160: 403-409
11. Travis J, Pike R, Imamura T, Potempa J: Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res 1997; 32: 120-125
12. Nakagawa S, Machida Y, Nakagawa T, Fujii H, Yamada S, Takazoe I, Okuda K: Infection by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans, and antibody responses at different ages in humans. J Periodontal Res 1994; 29: 9-16
13. Takahashi J, Saito A, Nakagawa T, Yamada S, Ishihara K, Okuda K: Dynamics of serum immunoglobulin G avidity for Porphyromonas gingivalis in adult periodontitis. J Periodontol 1998; 69: 367-373
14. Coles KA, Plant AJ, Riley TA, Smith DA: Cardiovascular disease: an infectious aetiology? Rev Med Microbiol 1998; 9: 17-27
15. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430-436
16. Okuda K, Ishihara K, Nakagawa T, Hirayama A, Inayama Y, Okuda K: Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol 2001; 39: 1114-1117
17. Scannapieco FA: Role of oral bacteria in respiratory infection. J Periodontol 1999; 70: 793-802
18. Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M, Page RC: Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun 1994; 62: 1026-1031
19. Booth V, Ashley FP, Lehner T: Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun 1996; 64: 422-427
20. Choi JI, Schifferle RE, Yoshimura F, Kim BW: Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Infect Immun 1998; 66: 391-393
21. Sims TJ, Schfferle RE, Ali R, Skaug N, Page RC: Serum IgG reactivity of periodontitis patients to K antigens of Porphyromonas gingivalis. In: Program and Abstracts, Annual Meeting. IADR, Vancouver, Canada, 1999
22. Schenck K, Helgeland K, Tollefsen T: Antibodies against lipopolysaccharide from Bacteroides gingivalis before and after periodontal treatment. Scand J Dent Res 1987; 95: 112-128
23. Vasel D, Sims TJ, Bainbridge B, Houston L, Darveau R, Page RC: Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol Immunol 1996; 11: 226-235
24. Evans RT, Klausen B, Sojar HT, Bedi GS, Sfintescu C, Ramamurthy NS, Golub LM, Genco RJ: Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun 1992; 60: 2926-2935
25. Fan Q, Sims T, Sojar H, Genco R, Page RC: Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes. Oral Microbiol Immunol 2001; 16: 144-152
26. Kokeguchi S, Kato K, Kurihara H, Nishimura F, Murayama Y: Purification and characterization of two major outer membrane proteins from Porphyromonas gingivalis. Dent Jpn (Tokyo) 1990; 27: 29-34
27. Okuda K, Kato T, Naito Y, Takazoe I, Kikuchi Y, Nakamura T, Kiyoshige T, Sasaki S: Protective efficacy of active and passive immunizations against experimental infection with Bacteroides gingivalis in ligated hamsters. J Dent Res 1988; 67: 807-811
28. Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL: Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis. J Periodontol 1998; 69: 686-697
29. Pike RN, Potempa J, McGraw W, Coetzer TH, Travis J: Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol 1996; 178: 2876-2882
30. Pike R, McGraw W, Potempa J, Travis J: Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem 1994; 269: 406-411
31. Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J: Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis 1999; 28: 456-465
32. Nakagawa T, Sims T, Fan Q, Potempa J, Travis J, Houston L, Page RC: Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis. Oral Microbiol Immunol 2001; 16: 202-211
33. Booth V, Lehner T: Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody which prevents colonization by the organism. J Periodontal Res 1997; 32: 54-60
34. Kelly CG, Booth V, Kendal H, Slaney JM, Curtis MA, Lehner T: The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis. Clin Exp Immunol 1997; 110: 285-291
35. Gibson FC 3rd, Genco CA: Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun 2001; 69: 7959-7963
36. Yonezawa H, Ishihara K, Okuda K: Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect Immun 2001; 69: 2858-2864
37. Inagaki S, Ishihara K, Takahashi J, Nakagawa T, Yamada S, Okuda K: Antibody response to gingipain R of porphyromonas gingivalis in periodontitis patients. J Dent Res 2001; 80: 651
38. Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J: A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun 1998; 66: 4108-4114
39. O'Brien-Simpson NM, Paolini RA, Reynolds EC: RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect Immun 2000; 68: 4055-4063
40. Kuboniwa M, Amano A, Shizukuishi S, Nakagawa I, Hamada S: Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect Immun 2001; 69: 2972-2979
41. Scragg MA, Alsam A, Rangarajan M, Slaney JM, Shepherd P, Williams DM, Curtis MA: Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells. Infect Immun 2002; 70: 5740-5750